The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Todd Engel, 62, was prescribed Ozempic in 2023 to manage his Type 2 diabetes. The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy ...

As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a growing swarm of lawsuits threatens to upend the billion ... Nine new GLP-1 drugs are in development by 34 companies, although many are ...

Novo Nordisk is accused in a suit of failing to warn that weight loss drug Ozempic could cause blindness. The plaintiff, a Maryland man, claims he developed non-arteritic anterior ischemic optic ...

Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there was no longer a shortage of semaglutide.

Todd Engel, 62, was prescribed Ozempic in 2023 to manage his Type 2 diabetes. The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy ...